Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition - PubMed (original) (raw)
Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition
Q He et al. J Cell Biol. 1992 Dec.
Abstract
We previously found that the CD44 glycoprotein on some lymphocytes can mediate adhesion to hyaluronate (HA) bearing cells. However, many questions remain about the molecular heterogeneity of CD44 and mechanisms which control its recognition of this ligand. In vitro mutagenesis and DNA sequencing have now been used to investigate the importance of the membrane proximal region of murine CD44 for recognition of soluble or cell surface HA. CD44 with an 83 amino acid deletion in this region mediated binding to soluble ligand and the apparent avidity increased markedly in the presence of a particular antibody to CD44, IRAWB14. The shortened CD44 was however inefficient in mediating adhesion of transfected cells to HA immobilized on cell surfaces. Four new murine isoforms of CD44 were isolated from a carcinoma line by use of the polymerase chain reaction. Only two of them correspond to ones recently discovered in rat and human cells. The longest variant nearly doubled the length of the extracellular portion of the molecule and introduced an additional 20 potential sites for glycosylation. When expressed on T lymphoma cells, all four of the new murine CD44 isoforms were capable of mediating adhesion to HA bearing cells. This result contrasts with a report that a related human CD44 isoform lacks this ability when expressed on B lineage lymphoma cells. The new murine isoforms also conferred the ability to recognize soluble HA and were very responsive to the IRAWB14 antibody. A brief survey of normal murine cell lines and tissues revealed that the hemopoietic isoform was the most abundant species. These findings indicate that the NH2-terminal portion of CD44 is sufficient for HA recognition and that this function is not necessarily abrogated by variations which occur in the membrane proximal domain. They add to the known molecular diversity of CD44 and provide another experimental model in which isoform specific functions can be investigated.
Similar articles
- Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade PW. Lesley J, et al. J Exp Med. 1992 Jan 1;175(1):257-66. doi: 10.1084/jem.175.1.257. J Exp Med. 1992. PMID: 1730918 Free PMC article. - Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF, Zhu D, Bourguignon LY. Welsh CF, et al. J Cell Physiol. 1995 Sep;164(3):605-12. doi: 10.1002/jcp.1041640319. J Cell Physiol. 1995. PMID: 7544357 - Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
Lokeshwar VB, Fregien N, Bourguignon LY. Lokeshwar VB, et al. J Cell Biol. 1994 Aug;126(4):1099-109. doi: 10.1083/jcb.126.4.1099. J Cell Biol. 1994. PMID: 7519619 Free PMC article. - CD44: structure, function, and association with the malignant process.
Naor D, Sionov RV, Ish-Shalom D. Naor D, et al. Adv Cancer Res. 1997;71:241-319. doi: 10.1016/s0065-230x(08)60101-3. Adv Cancer Res. 1997. PMID: 9111868 Review. - CD44 and the adhesion of neoplastic cells.
Rudzki Z, Jothy S. Rudzki Z, et al. Mol Pathol. 1997 Apr;50(2):57-71. doi: 10.1136/mp.50.2.57. Mol Pathol. 1997. PMID: 9231152 Free PMC article. Review.
Cited by
- Dendritic cell entry to lymphatic capillaries is orchestrated by CD44 and the hyaluronan glycocalyx.
Johnson LA, Banerji S, Lagerholm BC, Jackson DG. Johnson LA, et al. Life Sci Alliance. 2021 Mar 9;4(5):e202000908. doi: 10.26508/lsa.202000908. Print 2021 May. Life Sci Alliance. 2021. PMID: 33687996 Free PMC article. - CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.
Anand V, Khandelwal M, Appunni S, Gupta N, Seth A, Singh P, Mathur S, Sharma A. Anand V, et al. J Cancer Res Clin Oncol. 2019 Nov;145(11):2649-2661. doi: 10.1007/s00432-019-03024-9. Epub 2019 Sep 16. J Cancer Res Clin Oncol. 2019. PMID: 31529191 - Impact of structurally modifying hyaluronic acid on CD44 interaction.
Bhattacharya D, Svechkarev D, Souchek JJ, Hill TK, Taylor MA, Natarajan A, Mohs AM. Bhattacharya D, et al. J Mater Chem B. 2017;5(41):8183-8192. doi: 10.1039/C7TB01895A. Epub 2017 Sep 20. J Mater Chem B. 2017. PMID: 29354263 Free PMC article. - Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery.
Misra S, Hascall VC, Atanelishvili I, Moreno Rodriguez R, Markwald RR, Ghatak S. Misra S, et al. Int J Cell Biol. 2015;2015:537560. doi: 10.1155/2015/537560. Epub 2015 Sep 10. Int J Cell Biol. 2015. PMID: 26448753 Free PMC article. Review. - Regulation of Antigen-Experienced T Cells: Lessons from the Quintessential Memory Marker CD44.
Baaten BJ, Tinoco R, Chen AT, Bradley LM. Baaten BJ, et al. Front Immunol. 2012 Feb 27;3:23. doi: 10.3389/fimmu.2012.00023. eCollection 2012. Front Immunol. 2012. PMID: 22566907 Free PMC article.
References
- Cancer Res. 1978 Jul;38(7):2084-90 - PubMed
- J Cell Biol. 1984 Nov;99(5):1624-33 - PubMed
- J Cell Biol. 1992 Feb;116(3):817-25 - PubMed
- Biochem Biophys Res Commun. 1992 Jan 31;182(2):569-78 - PubMed
- J Exp Med. 1991 Oct 1;174(4):859-66 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous